Biological products and vaccine waste disposal workstation

Good manufacturing processes in vaccine production-Biological products and vaccine waste disposal workstation
Recently, many friends have consulted me about the safety of injections. During the cautious period, I have taken a rigorous attitude and combined my previous professional knowledge to investigate many materials related to vaccine production and research and development, vaccine type characteristics, etc. before answering; And inform them that they should respond to the national immunization call with confidence to receive immunization shots. And I also listed the credibility of China's current biotechnology and the country's high emphasis on public health, which are not comparable advantages to many Western countries.

Taking this opportunity, I will also share with you some rigorous requirements for vaccine research and development and manufacturing. I hope to increase everyone's initial understanding of past mysterious biological agents while also having more trust in Chinese technology.

The production and process control of vaccines are different from conventional drugs. However, this process is still based on the general management principles of good manufacturing processes.

Personnel Requirements:
Personnel and manufacturers should be under the leadership of personnel who have received training in the production process of biological substances.
Personnel working in clean and sterile areas should avoid any diseases or conditions that may harm the microbiological quality of the product.
Always adhere to high standards of personal hygiene and cleanliness.
All personnel should undergo health checks before employment, and regular health checks should be conducted thereafter.
Personnel should not be transferred from one area to another, especially if each area handles different live microorganisms or animals. This is only allowed if there is a clearly defined decontamination process.
The personnel assigned in production should be separated from the animal care personnel assigned.
Personnel involved in this process should receive training on good manufacturing and laboratory practices. These include bacteriology, biostatistics, virology, immunology, chemistry, and medicine.
Personnel involved in production, maintenance, testing and animal care should be vaccinated appropriately, and tuberculosis testing should be carried out regularly when appropriate.
Only individuals who have undergone regular health check ups are eligible to participate in the production of BCG vaccines.
It is recommended that personnel involved in the production of products derived from human plasma be vaccinated against hepatitis B.
premise
There must be a separate area for producing sterile biological products and handling animal tissues and microorganisms. Everyone must have an independent ventilation system and personnel.
Materials used for the production of biological products, such as cell banks, should be stored separately. Only authorized personnel are allowed to use these materials.
Only certain equipment that ensures the purity of the culture and is not contaminated during the process can be used to handle living organisms.
Through DNA technology, products made from toxins or bacterial extracts (such as inactivated vaccines) can be dispensed into containers in the same way as other sterile biological products, only after inactivation and with appropriate decontamination techniques.
There should be specialized facilities to handle spore forming organisms such as Bacillus anthracis, Clostridium botulinum, and Clostridium tetani.
There should be specialized facilities for producing products from human blood or plasma.
Only treat organisms considered pathogenic within specific areas of negative pressure.
production
The culture should be added to fermentation tanks and other similar containers to avoid contamination.
If inactivation is required during the manufacturing process, certain measures should be taken to avoid cross contamination.
There should be a clearly defined sterilization method.
labeling
All products should be properly labeled.
Regardless of storage conditions, labels should be affixed to the container. If it is not possible to label the container, the product should be placed in a labeled packaging.
The label should include the following information:
Product Name
Effective ingredients and the amount of each
Batch number or final batch number
deadline
Recommended storage conditions
Handling precautions (if necessary)
Instructions for use, warnings and precautions (if necessary)
The properties and quantities of substances that may cause adverse reactions
The name and address of the company or manufacturer responsible for this product
quality control
The quality control laboratory should be a separate facility; Ideally, it would be in a separate building.
Tests that are necessary for quality control but cannot be performed on the final product should be conducted during the production phase.
Both intermediate and final products should have sufficient quantities of samples to allow for repeated or confirmed batch control.
Unlike other drugs produced using predictable chemical processes, vaccine production requires a process that leads to inherent variability. Therefore, their production process and quality inspection are different from conventional drugs.

I am very grateful for understanding the production requirements of the above biological products and vaccines. Our country has a great plan for immunization and vaccine injection for over a billion people. At the same time, I also want to answer another question about vaccines: how to deal with so much waste after vaccine injection? What should be done after various vaccines have expired?
In fact, for vaccine research and production, as well as the disposal of expired vaccines and packaging waste after vaccination, a complete and safe set of disposal methods is indeed needed. Now I would like to recommend a safe, fast, energy-saving, and environmentally friendly value recycling technology for biological products and vaccine waste from Israel for everyone to understand. I believe that with the strict regulatory training and handling requirements of our staff, you will no longer have to worry about this issue.

CelitronBiological products and vaccine waste disposal workstation(Below image)

Plastic culture bottles for the research and production of pre processed vaccines and biological products (as shown in the figure below)

Safely and recyclable plastic after processing (as shown in the figure below)

After disposing of biomedical hazards, the treated waste is sterile, processed, broken, non-toxic, and essentially solid waste that can be treated as ordinary urban waste. By shredding waste into pressurized containers, the volume of waste can be reduced to 1/10 of its original volume, providing more opportunities for recycling.

The processed waste will be automatically unloaded into any standard waste container.
All elements, sterilization cycles, and parameters processed through the above facilities are customized according to the specific waste generated on site and mandatory requirements provided by vaccine manufacturers to ensure reliable, simple, and safe operation.

This fully automated closed system from Celitron meets the standards for life science laboratories (Class B), greatly reducing the risk of cross contamination, shortening the waste disposal process, and lowering related costs.